Das Buch ist derzeit nicht auf Lager
Parameter
- Seitenzahl
- 612 Seiten
- Lesezeit
- 22 Stunden
Mehr zum Buch
The book highlights the significant advancements in molecular medicines, noting that around 50 new drugs are approved annually by the FDA, with 25% being biopharmaceuticals. It details the introduction of over 200 recombinant proteins and monoclonal antibodies, as well as more than 60 biosimilars. Additionally, it discusses the rise of gene therapies using engineered viruses and cells. The comprehensive list of over 400 CMC regulatory compliance references, updated since the third edition, underscores the rapid evolution in this field.
Buchkauf
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals, John Geigert
- Sprache
- Erscheinungsdatum
- 2023
- product-detail.submit-box.info.binding
- (Hardcover)
Wir benachrichtigen dich per E-Mail.
Lieferung
Zahlungsmethoden
Hier könnte deine Bwertung stehen.